Picture of Surface Oncology logo

SURF — Surface Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall Cap

Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary

* Surface Oncology Inc  SURF.OQ  reported a quarterly adjusted
loss of 44 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 35 cents per share.
* Revenue was $515.00 thousand​;  analysts expected $2.47
million. 
* Surface Oncology Inc's reported EPS for the quarter was a loss
of 44 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Surface Oncology Inc shares had fallen by 24.8% this
quarter and lost 39.3% so far this year.
* The company reported a quarterly loss of $18.98 million.
* Wall Street's median 12-month price target for Surface
Oncology Inc is $15.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 6 at 06:38 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Surface Oncology

See all news